These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20000865)

  • 1. Resolving a double standard for risk management of thalidomide: an evaluation of two different risk management programmes in Japan.
    Ooba N; Sato T; Watanabe H; Kubota K
    Drug Saf; 2010 Jan; 33(1):35-45. PubMed ID: 20000865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personal imports of drugs to Japan in 2005--an analysis of import certificates.
    Tsuji K; Tsutani K
    J Clin Pharm Ther; 2008 Oct; 33(5):545-52. PubMed ID: 18834370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk Management of Teratogenic Drugs ~The Current States of Practice in Europe, US and Japan~].
    Takagi T; van Bennekom C; Amann S; Hattori C; Shirakuni Y; Sato T; Nasu M
    Yakugaku Zasshi; 2015; 135(10):1161-8. PubMed ID: 26234426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective risk management programmes.
    Donawa M
    Med Device Technol; 2004 May; 15(4):28-30. PubMed ID: 15303561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Japanese regulatory system for approval of off-label drug use: evaluation of safety and effectiveness in literature-based applications.
    Shimazawa R; Ikeda M
    Clin Ther; 2012 Oct; 34(10):2104-16. PubMed ID: 23036337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report.
    Chen B; Restaino J; Norris L; Xirasagar S; Qureshi ZP; McKoy JM; Lopez IS; Trenery A; Murday A; Kahn A; Mattison DR; Ray P; Sartor O; Bennett CL
    J Oncol Pract; 2012 Nov; 8(6):e158-67. PubMed ID: 23598851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaceutical risk management in Turkey: the first national overview.
    Aydinkarahaliloglu ND; Aykac E; Kasap Y; Durmus N; Babacanoglu C; Basgut CE; Artiran G; Kerman S
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):344-50. PubMed ID: 23994623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reported use of thalidomide in multiple myeloma: presentation of problems in the Thaled® outpatient department].
    Aimono Y; Sato W; Otani E; Isa S; Sawahata T; Onozaki M; Saito Y; Ebata S; Aoyama Y; Hakozaki M; Suzuki M; Kudo D; Monma Y; Chikatsu N; Shinagawa A
    Gan To Kagaku Ryoho; 2011 Dec; 38(13):2579-84. PubMed ID: 22189222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial.
    Katayama K; Misawa S; Sato Y; Sobue G; Yabe I; Watanabe O; Nishizawa M; Kusunoki S; Kikuchi S; Nakashima I; Ikeda S; Kohara N; Kanda T; Kira J; Hanaoka H; Kuwabara S;
    BMJ Open; 2015 Jan; 5(1):e007330. PubMed ID: 25573527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Japanese guideline on thalidomide usage in the management of erythema nodosum leprosum].
    Ishii N; Ishida Y; Okano Y; Ozaki M; Gidoh M; Kumano K; Goto M; Nogami R; Hatano K; Yamada A; Yotsu RR
    Nihon Hansenbyo Gakkai Zasshi; 2011 Sep; 80(3):275-85. PubMed ID: 21941834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reconsideration of the admission and discharge criteria of tuberculosis patients in Japan].
    Masuyama H; Igari H
    Kekkaku; 2013 Mar; 88(3):373-85. PubMed ID: 23672177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a Pregnancy Prevention Programme (PPP) with a Controlled Distribution System (CDS) for the Generic Teratogenic Phthalimides Thalidomide, Lenalidomide and Pomalidomide.
    Mueller M; Lewis DJ
    Ther Innov Regul Sci; 2021 Nov; 55(6):1155-1164. PubMed ID: 34331266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic risk management interventions: feasibility and effectiveness.
    Andrews E; Gilsenan A; Cook S
    J Am Pharm Assoc (2003); 2004; 44(4):491-500. PubMed ID: 15372870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the QSR/GMP, and why should you care?
    Bartoo G
    IEEE Eng Med Biol Mag; 2004; 23(2):98-9. PubMed ID: 15264479
    [No Abstract]   [Full Text] [Related]  

  • 15. Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study.
    Tacchetti P; Pantani L; Patriarca F; Petrucci MT; Zamagni E; Dozza L; Galli M; Di Raimondo F; Crippa C; Boccadoro M; Barbato S; Tosi P; Narni F; Montefusco V; Testoni N; Spadano A; Terragna C; Pescosta N; Marzocchi G; Cellini C; Galieni P; Ronconi S; Gobbi M; Catalano L; Lazzaro A; De Sabbata G; Cangialosi C; Ciambelli F; Musto P; Elice F; Cavo M;
    Lancet Haematol; 2020 Dec; 7(12):e861-e873. PubMed ID: 33242443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access to thalidomide for the treatment of multiple myeloma in Canada: physician behaviours and ethical implications.
    Minuk L; Sibbald R; Peng J; Bejaimal S; Chin-Yee I
    Curr Oncol; 2010 Aug; 17(4):11-9. PubMed ID: 20697510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary care physician opinion survey on FDA opioid risk evaluation and mitigation strategies.
    Slevin KA; Ashburn MA
    J Opioid Manag; 2011; 7(2):109-15. PubMed ID: 21561034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating risk management into the CAPA process.
    Bills E; Tartal J
    Biomed Instrum Technol; 2008; 42(6):466-8. PubMed ID: 19012461
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of Drugs Approved by Public Knowledge-Based Applications (Kouchi-shinsei) During the Last Two Decades in Japan.
    Maeda H; Fukuda Y; Uchida M
    Clin Pharmacol Ther; 2021 Oct; 110(4):1127-1135. PubMed ID: 34110632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide for the treatment of multiple myeloma.
    Hattori Y; Iguchi T
    Congenit Anom (Kyoto); 2004 Sep; 44(3):125-36. PubMed ID: 15327481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.